Ionis' 2016 Financial Results Outperform Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Ionis Pharma (IONS) Tops Q4 EPS by 33c
February 28, 2017 7:09 AM ESTIonis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.21, $0.33 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $160.3 million versus the consensus estimate of $97.47 million.
For earnings history and earnings-related data on Ionis Pharma (IONS) click here.
... More


